78 related articles for article (PubMed ID: 26135929)
1. A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update.
Chen Y; Zhong H; Gao JG; Tang JE; Wang R
Urol J; 2015 Jul; 12(3):2138-47. PubMed ID: 26135929
[TBL] [Abstract][Full Text] [Related]
2. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
3. Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.
Mi Y; Zhang L; Feng N; Wu S; You X; Shao H; Dai F; Peng T; Qin F; Zou J; Zhu L
PLoS One; 2012; 7(9):e44756. PubMed ID: 23028604
[TBL] [Abstract][Full Text] [Related]
4. Association of XPC gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects.
Zou YF; Tao JH; Ye QL; Pan HF; Pan FM; Su H; Ye DQ
Genet Test Mol Biomarkers; 2013 Dec; 17(12):926-31. PubMed ID: 24093803
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.
Zhu H; Cao S; Liu Y; Ding X; Wu Q; Ma H
J Cancer Res Ther; 2013; 9(2):187-92. PubMed ID: 23771356
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between XPC Lys939Gln polymorphism and prostate cancer risk: an updated meta-analysis based on 3039 cases and 3253 controls.
Wu H; Lv Z; Wang X; Zhang L; Mo N
Int J Clin Exp Med; 2015; 8(10):17959-67. PubMed ID: 26770390
[TBL] [Abstract][Full Text] [Related]
7. Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.
Yan Y; Xu J; Xu B; Wen Q; Zhou J; Zhang L; Zuo L; Lv G; Shi Y
J Clin Lab Anal; 2020 Sep; 34(9):e23403. PubMed ID: 32488882
[TBL] [Abstract][Full Text] [Related]
8. Common variants of xeroderma pigmentosum genes and prostate cancer risk.
Mirecka A; Paszkowska-Szczur K; Scott RJ; Górski B; van de Wetering T; Wokołorczyk D; Gromowski T; Serrano-Fernandez P; Cybulski C; Kashyap A; Gupta S; Gołąb A; Słojewski M; Sikorski A; Lubiński J; Dębniak T
Gene; 2014 Aug; 546(2):156-61. PubMed ID: 24933002
[TBL] [Abstract][Full Text] [Related]
9. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ
Mol Vis; 2015; 21():335-46. PubMed ID: 25873778
[TBL] [Abstract][Full Text] [Related]
10. Poly (AT) polymorphism in the XPC gene and smoking enhance the risk of prostate cancer in a low-risk Chinese population.
Liu Y; Chen Z; Wei Q; Yuan F; Zhi Y; Song B; Yang J
Cancer Genet; 2012 May; 205(5):205-11. PubMed ID: 22682619
[TBL] [Abstract][Full Text] [Related]
11. ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis.
Chang X; Wang H; Yang Z; Wang Y; Li J; Han Z
Medicine (Baltimore); 2023 Jun; 102(23):e33937. PubMed ID: 37335680
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
13. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
Srivastava P; Kapoor R; Mittal RD
Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
[TBL] [Abstract][Full Text] [Related]
14. The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis.
Yang J; Gao W; Song NH; Wang W; Zhang JX; Lu P; Hua LX; Gu M
Asian J Androl; 2012 Sep; 14(5):726-31. PubMed ID: 22902907
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
16. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
[TBL] [Abstract][Full Text] [Related]
17. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
[TBL] [Abstract][Full Text] [Related]
18. DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis.
Mocellin S; Verdi D; Nitti D
Carcinogenesis; 2009 Oct; 30(10):1735-43. PubMed ID: 19706646
[TBL] [Abstract][Full Text] [Related]
19. Association of Vitamin D receptor Fok I polymorphism with the risk of prostate cancer: a meta-analysis.
Kang S; Zhao Y; Liu J; Wang L; Zhao G; Chen X; Yao A; Zhang L; Zhang X; Li X
Oncotarget; 2016 Nov; 7(47):77878-77889. PubMed ID: 27788484
[TBL] [Abstract][Full Text] [Related]
20. Association of 17q24 rs1859962 gene polymorphism with prostate cancer risk: A systematic review and meta-analysis.
Ren F; Zhang P; Ma Z; Zhang L; Li G; Huang X; Chang D; Yu X
Medicine (Baltimore); 2020 Jan; 99(3):e18398. PubMed ID: 32011434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
